chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (Fever) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, ATORVASTATIN, METOPROLOL and METFORMIN for an unknown indication, FAMOTIDINE (PEPCID AC).   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 1. On 05-Feb-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature (100-102.5): 100 and 102.5 Temperature was running between 100 and 102.5, yesterday it was below 98 and today it is mild 98.9.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non significant follow up received on 05-MAY-2021, no new information
Child received 12 MO vaccines and within 2-3 min became red on thighs BIL around injection site and on (R) upper arm and face. Gave 1 dose BENADRYL and almost completely cleared within 10-15 min.
Pain in his lower extremities and torso. Pain on  breathing inspiration, and observed with a nosebleed.
12/19/22 presents to ED ED for "shortness of breath". PMHx of "dilated cardiomyopathy, hypertension hyperlipidemia sleep apnea rheumatoid arthritis GERD anemia BPH."
The night after getting her vaccines, the patient reports having a migraine, a great deal of arm pain, and a fever. This persisted through the next evening, and a rash a few inches below the injection site appeared. Today, this rash is still there, but she is feeling about 85% better.
report a side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (report a side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (report a side effect). At the time of the report, ADVERSE EVENT (report a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication was reported
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On an unknown date in 2016, the patient was treated at a hospital for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Received the second Moderna shot on 4-22-21 at 5:00pm. Noticed the next day around noon that my sense of taste and smell were greatly diminished. Food that had a strong taste and smell came across as weak or had no taste. I could not smell strong scents around the house ( hand soaps ) unless I held it up to my noise.
known exposure 2 1/2wk ago;mild case of varicella less than 50 lesions all dried;never devel fever;
"feeling lips swelling, tip of tongue swelling and throat itchy.   No difficulty swallowing, v/s 99 oxygen sat 2l nc placed for comfort p 74 bp 155/93. PA  called at patients side v/o for epi x1 and 911 called. Epipen 0.3mg syringe pen administered IM to left thigh. Pt taken by ambulance to     ED
Rapid Heart rate ,  Heart palpitations within 15 minutes of receiving vaccine.    Pulse 122. when checked by EMT.     Waited half hour longer went home.  About 4 hours later went to  . ER   B/p 204/104 Pulse 108 at check in.
About 5 or 6 hours after the shot , I developed body aches and chills and had a fever of 101. This lasted through the night, along with a sharp pain in my chest that developed in the night and radiated from front to back, which made it difficult to sleep. During the night, I took some rolaids and moved the couch to sleep more upright, because I think the pain may have been heartburn or some other GI thing (I rarely get this feeling, but I have had it before, and my last meal of the day was several hours before i went to bed and before my symptoms started). By morning the next day (Sunday), my whole left arm was achy, down to my hand and fingers, and my right arm also but not as severe. My left armpit felt tender (and still does today, but not as bad).  By mid-day, I started to feel better, the fever was gone, and by late afternoon, the body aches were gone. My left arm and hand was still tender, but not as bad. By Sunday night i would say I was back to about 80%, and by Monday morning, 95%, and by late Monday morning, back to normal, other than the slight tenderness I still feel (today being Tuesday) in my left armpit.
developed a latex allergy; This is a spontaneous report received from a contactable reporter(s) (Pharmacist), Program ID:   A 90-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 Immunization. The following information was reported: RUBBER SENSITIVITY (non-serious), outcome "unknown", described as "developed a latex allergy".  Additional information: The pharmacist called from pharmacy mentioned that she has a 90 year old customer called her this morning who recently developed a latex allergy and was questioning whether there was any latex in the new bivalent adult vaccine.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Case number PHEH2014US014993, is an initial spontaneous report from a medical assistant received on 24 Jul 3014 with a follow-up from a medical assistant received on 21 Oct 2014. This report refers to a 17-year-old male patient. Past medical history and concomitant medications were not provided. His vaccination status was up-to-date. He was vaccinated with 0.5 ml of expired MENVEO (batch number: M11075) intramuscularly into left arm on 11 Mar 2014. No adverse event was reported following this administration error. Follow up information received from the medical assistant on 21 Oct 2014: Patient demographics (height and weight) and site of vaccination (left arm) were updated.
Patient came in to get 3rd covid shot. After she was administered the vaccine she came back about an hour later and showed me CDC card which her first 2 doses were Moderna. The immunizing tech  missed the manufacture on the CDC  card which was not done at our location
I have a swollen lymph node in the left armpit, which is the same arm of my booster vaccine. When I received my second dose 6 months ago, I had the same side effect. It is very large, swollen and pain; painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 11:45 (Batch/Lot number: unknown) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing), notes: Hypothyroidism; "high blood pressure" (unspecified if ongoing), notes: high blood pressure. The patient's concomitant medications were not reported. Past drug history included: Augmentin, reaction(s): "Known Allergy: Augmentin", notes: Augmentin. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Vaccine location-Left arm.Unable to locate or read the details), for COVID-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details), administration date: 2021, for COVID-19 Immunization, reaction(s): "swollen lymp node in the left armpit"; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details), administration date: 2021, for Covid 19 Immunization, reaction(s): "painful lymph nodes".The following information was reported: LYMPHADENOPATHY (non-serious) with onset 23Oct2021 07:00, outcome "recovering", described as "I have a swollen lymph node in the left armpit, which is the same arm of my booster vaccine. When I received my second dose 6 months ago, I had the same side effect. It is very large, swollen and pain"; PAIN (non-serious) with onset 23Oct2021 07:00, outcome "recovering", described as "painful". Therapeutic measures were not taken as a result of lymphadenopathy, pain.  Additional Information:Patient received other vaccine on same date as dose 3 on Left Arm (dose number 1).No other vaccines were received within 4 weeks prior to the COVID vaccine.Prior to vaccination,patient was not diagnosed with COVID-19.Since the vaccination, patient been not tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt was unresponsive 5 min into getting the shot. It could've been possible anaphylactic reaction. Called 911 right away and Rph gave Epipen 0.3 injection. Pt did not lose consciousness though.
Patient was seen 09/20/2005 and received MMR, DTap, Hib, PCV7. 6 days later presented with thrombocytopenia, Dx ITP after bone marrow exam. Hematologist at Hospital felt as thought the MMR was the precipitating cause. Treated with IVIG and oral steroids. 11/21/05 review of d/c summary done. Final diagnosis was ITP.
Patient presents back to the clinic about 40 minutes after receiving Covid vaccine with c/o thick tongue and tingly throat.  She also has bright red cheeks and a slight rash on her neck.  Denies shortness of breath.  Visited with healthcare professional and she recommends giving her Benadryl 50 mg IM.  This was administered into left gluteal.  Sat with patient and she does feel like the Benadryl has given her some relief.  Asmanex inhaler also given to patient per medical professional's order.  She should take bid.
Patient's mother called me on 8/1/20 in the morning and told me that Patient has had two episodes of lifelessness during the past two nights that she is scared about. She states that on 7/31/20 at 1 am she happened to wake up and went to check on Patient. She said that "he was grey and lifeless, he went limp and i snatched him up. I thought he was dead, and he was still just lifeless and wasn't breathing and I started smacking his back and after about 4 smacks he took a breath and gave a cry then went back to sleep." Mom believes that if she didn't happen to get up and see him at that time, that he would have been dead when she woke up in the morning. She said a similar thing happened the following night, but not as severe. The patient is otherwise acting completely normal and isn't showing any signs of illness. He is eating well and playful and happy.
shortness of breath-subsided O2 98%, HR 70 RR 18 BP 114/73 fatigue itchiness "cold/hot"
Special note:  Patient is a nurse in the immunization clinic.   Within 5 minutes after injection patient had itching at right arm injection site, chest tightness, and throat itching, shortness of breath.  Patient took two (2) puffs of Albuteral inhaler at 4:45 pm.  Experienced loud pulmonary wheezing at 5:30 pm.  Patient took Xophrenox per nebulizer x2 treatments consecutively.  Within the hour patient took 3rd Xophrenox treatment with decrease in wheezing and shortness of breath.  No problems at injection site other than itching which did not increase later in the day.  Patient also experienced cyanosis around mouth with wheezing episode.
Information has been received from a health professional concerning a patient who about two weeks ago was vaccinated IM with a 0.5 mL dose of pneumococcal 23v polysaccharide vaccine (658450/1380U). On the same day of vaccination, the patient experienced injection site redness, swelling and pain. Unknown medical attention was sought. The patient's was recovered. No product quality complaint was involved. This is one of multiple reports from the same source. Other (WAES# 0802USA02058 and 0802USA05541). Additional information has been requested.
1 1/2 day later noticed itching at site on (R) arm. This progressed to redness & some mild swelling. The next day (2 days after imm) redness worsened & she came in with blister in area. Tx'd with ABX for cellulitis & advised to continue ZYRTEC OTC & RTC for recheck after 24hrs.
Rash on injection site, left arm appeared one week after first vaccination shot. "Covid rash"
No issues with shot upon receiving. Two weeks after shot I began having hive like symptoms but no itching. Skin is red and bumpy. Has not gone away at all. Actually seems to be spreading.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to an adult female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In September 2016, the patient was inoculated with ZOSTAVAX at a medical office as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles or zoster-related injuries as intended and the patient subsequently developed zoster-related vision loss and other complications. In 2017, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Upon internal review, zoster-related vision loss was considered to be medically significant. Additional information has been requested.
Back pain around left shoulder blade Chest pain right under left clavicle  Muscle tightness (feels hard to touch) around injection site  Headache Body aches (just upper body)
Didn't have any immediate reaction to the vaccine, however the next day I awakened to a swollen top lip.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Sep2021 at 16:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included proteinuria. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient did not have any immediate reaction to the vaccine. However, the next day on 25Sep2021 at 07:00, the patient awakened to a swollen top lip. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen top lip was resolving at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Within 5 minutes of the injection I developed a metalic/medicinal taste in my mouth. It lasted for about 3 days.  There was a slight medicinal odor to my breath, similar to what I've experinced after having anethesia.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 05-NOV-2013, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # H018455 and expiry date: 09-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Rash at site of injection LD given im. Rash moved down arm to back and then all body. When health dept called on 10 17/08 it was resolving. Did not go to Dr. or ER.
Slightly heightened (for a few days) immune system reactions; Somewhat more uncomfortable post-vaccine time; Normal post-vaccine reactions (a few days only each time); This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59-year-old female patient received bnt162b2 (BNT162B2), on 01Feb2021 as dose 1, single (Lot number: EL3247) at the age of 59 years intramuscular, in right arm for COVID-19 immunisation. The patient's relevant medical history included: "Multiple chemical sensitivities" (unspecified if ongoing); "Graves' disease" (unspecified if ongoing), notes: in remission. The patient's concomitant medications were not reported. The following information was reported: IMMUNE SYSTEM DISORDER (non-serious), outcome "recovered", described as "Slightly heightened (for a few days) immune system reactions"; DISCOMFORT (non-serious), outcome "unknown", described as "Somewhat more uncomfortable post-vaccine time"; IMMUNISATION REACTION (non-serious), outcome "recovered", described as "Normal post-vaccine reactions (a few days only each time)". Additional information: The patient reported that overall she had normal immune system reactions to COVID-19 vaccines. She had nothing relevant to family medical history other than slightly heightened (for a few days) immune system reactions - no follow-up care needed from any medical facility or physician. She has multiple chemical sensitivities and Grave's disease (in remission). Over reactive immune system in general. Probably contributed to a somewhat more uncomfortable post-vaccine time. She had normal post-vaccine reactions (a few days only each time), each of the 4 times she was vaccinated against COVID-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201279899 same patient, vaccine, and event; different dose;
the same day vax recv pt devel t105&was inconsolable for 3hr;that noc fever dropped to 101;no local rxn noted,episodes of drowsiness 28MAR96;pt improved,not inc temp but sl irritable&tired;
Several days after vaccine administration patient developed shortness of breath, orthopnea, tachycardia, leg swelling, cough. Seen by Cardiology outpatient, had Echo which showed EF 15%. Admitted to medical center. Patient diagnosed with myocarditis  post vaccine administration by ID.
INTERMITTENT SHORT OF BREATH; UNCONTROLLABLE CHILLS; SEVERE HEADACHE; FEVER; FATIGUE; LIGHT-HEADED; EXCORIATING BACK PAIN; PROFUSE SWEATING; VOMITING; STOMACH PAIN; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 20-MAR-2021, the subject experienced light-headed. On 20-MAR-2021, the subject experienced excoriating back pain. On 20-MAR-2021, the subject experienced profuse sweating. On 20-MAR-2021, the subject experienced vomiting. On 20-MAR-2021, the subject experienced stomach pain. On 20-MAR-2021, the subject experienced severe headache. On 20-MAR-2021, the subject experienced fever. On 20-MAR-2021, the subject experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 103 F. On 20-MAR-2021 20:00, the subject experienced uncontrollable chills. On 21-MAR-2021, the subject experienced intermittent short of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from light-headed, and uncontrollable chills on 20-MAR-2021, excoriating back pain, profuse sweating, severe headache, and fever on 22-MAR-2021, vomiting on 21-MAR-2021, and intermittent short of breath, and fatigue on MAR-2021, and had not recovered from stomach pain. This report was non-serious.
This pt experienced nausea and abdominal spasms and had difficulty breathing within 24 hours post vax. The abdominal spasms persisted for approximately 4 months, through 03/29/1999. He was seen by a local physician and a specialist. He has been prescribed Prevacid for GERD. His abdominal spasms persist despite treatment efforts. He was placed on a liquid diet for a period of time but has restarted solids recently.  From follow-up #1 information received on 1-May-2001.  It was reported that the patient's recovery status is unknown.  Last seen in September 1999.  No further information available regarding this patient or this case.  This case is closed.
Low grade fever after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever after second shot) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PYREXIA (Low grade fever after second shot). In March 2021, PYREXIA (Low grade fever after second shot) outcome was unknown.            No concomitant medications was reported. No treatment drug details was reported.